Phase 1 Acute Ischemic Stroke Clinical Trials
5 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–5 of 5 trials
Recruiting
Phase 1Phase 2
A Study of the Safety, Tolerability and Preliminary Efficacy of B2065 in Patients With Acute Ischemic Stroke.
Acute Ischemic Stroke
Tasly Pharmaceutical Group Co., Ltd54 enrolled1 locationNCT07371624
Recruiting
Phase 1Phase 2
The Effect of GD-iExo-003 in Acute Ischemic Stroke
Acute Ischemic Stroke
Xuanwu Hospital, Beijing29 enrolled1 locationNCT06138210
Recruiting
Phase 1Phase 2
Qingre Huatan Formula for the Prevention of Early Neurological Deterioration in Acute Ischemic Stroke
Acute Ischemic Stroke
Dongzhimen Hospital, Beijing72 enrolled1 locationNCT06857487
Recruiting
Phase 1
Study on Hibernation-like Therapy Based on Mechanical Thrombectomy
Acute Ischemic Stroke
Capital Medical University32 enrolled1 locationNCT06663631
Completed
Phase 1
A Phase 1 study to evaluate Safety, Tolerability and Pharmacokinetics of LMR-123 in Healthy Subjects
Acute Ischemic Stroke
Australia Medical Industries Pty Ltd.52 enrolled1 locationACTRN12619001609145